Aphel Online
The cell therapy market has emerged as a significant segment within the biopharmaceutical industry, driven by the increasing prevalence of chronic diseases and a surge in research funding. Valued at USD 16.30 billion in 2023, the market is anticipated to grow at a compound annual growth rate (CAGR) of 18.1%, reaching USD 72.84 billion by […]
The cell therapy market is experiencing unprecedented growth, driven by the increasing burden of chronic diseases and significant investments in cell therapy research. Valued at USD 16.30 billion in 2023, the market is projected to reach USD 72.84 billion by 2032, growing at a robust CAGR of 18.1% from 2024 to 2032. This growth is […]